| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Nurix Therapeutics, Inc. (NRIX) have been net sellers, shedding 49,260 shares worth roughly $1.2M on balance. In the past 30 days, 0 insiders bought and 4 sold.
All 4 insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 123.5K | $3.19M | -6,861 | |
| CFO | 47.5K | $1.23M | -2,834 | |
| Other | 15.3K | $395.9K | -3,957 | |
| Dir | 10.8K | $277.6K | -22,583 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2025 | Hans van Houte56 | Chief Financial Officer | Sale+OE | 2,811 | $19.85 | $55,808.69 | -6.6% | -42.4% | -17.5% | |
| Jan 2, 2025 | Christine Ring75 | Chief Legal Officer | Sale+OE10b5-1 | 5,760 | $19.50 | $112,294.66 | -17.0% | -41.7% | -7.4% | |
| Dec 2, 2024 | Christine Ring75 | Chief Legal Officer | Sale+OE10b5-1 | 5,760 | $21.73 | $125,155.01 | -17.0% | -34.0% | -23.9% | |
| Nov 4, 2024 | Christine Ring75 | Chief Legal Officer | Sale+OE10b5-1 | 3,290 | $25.00 | $82,250.00 | -10.5% | -24.3% | -51.0% | |
| Nov 1, 2024 | Christine Ring75 | Chief Legal Officer | Sale+OE10b5-1 | 5,760 | $24.28 | $139,866.62 | -17.0% | -18.2% | -47.1% | |
| Nov 1, 2024 | Hans van Houte56 | Chief Financial Officer | Sell10b5-1 | 3,546 | $24.28 | $86,083.41 | -9.5% | -18.2% | -47.1% | |
| Oct 30, 2024 | Hans van Houte56 | Chief Financial Officer | Sale+OE | 2,368 | $24.31 | $57,554.24 | -6.0% | -18.7% | -46.9% | |
| Oct 30, 2024 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 3,437 | $24.31 | $83,536.29 | -6.4% | -18.7% | -46.9% | |
| Oct 30, 2024 | Christine Ring75 | Chief Legal Officer | Sale+OE | 4,182 | $24.31 | $101,643.51 | -13.0% | -18.7% | -46.9% | |
| Oct 14, 2024 | Christine Ring75 | Chief Legal Officer | Sale+OE10b5-1 | 3,290 | $25.00 | $82,250.00 | -11.8% | -24.4% | -63.5% |